LBO — OVERLOOK MEDICAL CENTER
IRR: 18.0% | MOIC: 2.29x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
18.0%
IRR
2.29x
MOIC
$806.3M
Entry EV
$1.3B
Exit EV
$414.9M
Equity Invested
Sources & Uses
S&UTotal · $806.3M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $313.1M | 38.8% | |
| Sub Debt | $78.3M | 9.7% | |
| Equity | $414.9M | 51.5% | |
| Enterprise Value | $782.8M | 97.1% | |
| Transaction Fees | $23.5M | 2.9% | |
| Total Uses | $806.3M | 100.0% |
Interpretation
INTAt 2.29x MOIC and 18.0% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $122.0M |
| Exit Ev | $1.3B |
| Net Debt At Exit | $332.9M |
| Equity At Exit | $948.2M |
| Equity Invested | $414.9M |
| Total Value Created | $533.3M |
| Value From Growth | $459.2M |
| Value From Multiple | $39.1M |
| Value From Deleveraging | $58.5M |